Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?

CapMan Q3’25: Light at the end of the tunnel in the fundraising market

CapMan

CapMan’s Q3 was slightly better than expected. Q3 revenue grew clearly due to the acquisitions completed earlier in the year. Management fees and wealth management fees developed slightly better than we expected, and overall, the fee mix was better than we expected. Analyst Sauli Vilén summarizes.

Read the latest company report here.

Stay up to date
Analyst Interviews

Recent videos

HCA Morgenbørs 07/01 - Vi ser ind i en blandet udvikling på de globale futures-markeder med Europa i plus og USA i minus
07.01.2026, 09.58 RTX
Roblon – Præsentation af årsregnskabet for 2024/25
06.01.2026, 10.00 Roblon
HCA Morgenbørs 06/01 - Europæiske futures indikerer at vi forlænger Santa Claus rally'et
06.01.2026, 09.18 Novo Nordisk
HCA Morgenbørs 05/01 - Positive europæiske futures og fokus på Novo Nordisk, Gubra og ISS
05.01.2026, 09.16 Novo Nordisk
Investor Day | Nov. 24, 2025
23.12.2025, 11.00 United Bankers
View all videos
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.